all report title image

SEXUAL HEALTH MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Sexual Health Market, By Product Type (Erectile Dysfunction Drugs, Gender Dysphoria Drugs, Hypoactive Sexual Desire Disorder Drugs, Premature Ejaculation Drugs, Others), By Gender (Male, Female), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In: 15 Apr, 2026
  • Code: CMI3364
  • Page number: 151
  • Formats:   Excel and PDF
  • Industry: Healthcare IT
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026 - 2033

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Gender
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Technology Advancements
    • Merger and Acquisition
    • Regulatory Scenario
    • PORTER’S Five Forces
    • PEST Analysis
  4. Global Sexual Health Market, By Product Type, 2021– 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Erectile Dysfunction Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Gender Dysphoria Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Hypoactive Sexual Desire Disorder Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Premature Ejaculation Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
  5. Global Sexual Health Market, By Gender, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Male
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Female
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
  6. Global Sexual Health Market, By Distribution Channel, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Retail Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Online Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
  7. Global Sexual Health Market, By Region, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, By Region, 2022 – 2033
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Gender, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Gender, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Gender, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Gender, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Gender, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Gender, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 – 2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Meda Pharmaceuticals, Inc.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Eli Lilly & Company
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Bayer AG
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Vivus, Inc.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Zydus Pharmaceuticals
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • IVFTECH APS
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Merck & Co.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Pfizer Inc.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Sun Pharmaceutical Industries Ltd
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Novartis International AG
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Mylan Pharmaceuticals Inc.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • AstraZeneca
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.